Home | Business News | Browse by Publication | P | Pharma Marketletter

Glivec cleared for five new disorders in USA.

Publication: Pharma Marketletter
Publication Date: 30-OCT-06
Format: Online
Delivery: Immediate Online Access
Full Article Title: Glivec cleared for five new disorders in USA.(Brief article)

Article Excerpt
Swiss drug major Novartis says that its breathrough drug Glivec (imatinib) has received US regulatory approval to treat five distinct and potentially life-threatening disorders. The Food and Drug Adminsitration cleared the tyrosine kinase inhibitor for the treatment of the solid tumor cancer, dermatofibrosarcoma protuberans, relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Pharma Marketletter
OOPD grant from FDA for PTC Therapeutics.(Food and Drug Administration..., October 30, 2006
Xencor raises $45M in private placing.(Brief article), October 30, 2006
Dendrite UK announces Infonetica deal.(Dendrite UK contract with Infon..., October 30, 2006
IMS Health expands in oncology expertise.(Brief article), October 30, 2006
Headlines 25 years ago this week....(Brief article), October 30, 2006

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.